Aug 1 (Reuters) - ACCC -
- EXPRESSED PRELIMINARY COMPETITION CONCERNS ABOUT QANTAS' ACQUISITION OF A 19.9% INTEREST IN ALLIANCE AIRLINES
- CONSIDERS THIS SHAREHOLDING HAS POTENTIAL TO IMPACT ALLIANCE'S FUTURE GROWTH AND ITS ABILITY TO BE A STRONG COMPETITOR
- QANTAS DID NOT SEEK INFORMAL MERGER CLEARANCE FROM ACCC BEFORE IT ACQUIRED STAKE IN ALLIANCE
- QANTAS HAS PROVIDED AN UNDERTAKING NOT TO ACQUIRE ANY FURTHER INTEREST IN ALLIANCE UNTIL INVESTIGATION IS COMPLETED
- CONTINUING TO INVESTIGATE WHETHER THIS ACQUISITION IS LIKELY TO HAVE EFFECT OF SUBSTANTIALLY LESSENING COMPETITION
- ALLIANCE IS QANTAS' ONLY COMPETITOR ON REGULAR PASSENGER TRANSPORT ROUTE BETWEEN BRISBANE & IMPORTANT REGIONAL CENTRES OF BUNDABERG & GLADSTONE
Source text : [http//bit.ly/311zvOy]
(([email protected];))
- Forums
- ASX - By Stock
- AQZ
- News: AQZ ACCC Expresses Preliminary Concerns About Qantas' Acquisition Of Stake In Alliance...
AQZ
alliance aviation services limited
Add to My Watchlist
1.13%
!
$2.68

News: AQZ ACCC Expresses Preliminary Concerns About Qantas' Acquisition Of Stake In Alliance...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.68 |
Change
0.030(1.13%) |
Mkt cap ! $431.3M |
Open | High | Low | Value | Volume |
$2.60 | $2.71 | $2.60 | $176.3K | 65.42K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $2.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.72 | 1900 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 2.640 |
1 | 2500 | 2.630 |
1 | 200 | 2.600 |
1 | 1000 | 2.520 |
2 | 1000 | 2.500 |
Price($) | Vol. | No. |
---|---|---|
2.720 | 1900 | 1 |
2.730 | 1000 | 1 |
2.750 | 5000 | 2 |
2.780 | 4790 | 1 |
2.790 | 4020 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AQZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online